Trial of EXenatide in Acute Ischaemic Stroke
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Acute Ischemic Stroke
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03287076
- Collaborators
- National Health and Medical Research Council, Australia
- Monash University
- Investigators
- Principal Investigator: Christopher Bladin The Florey Institute of Neuroscience & Mental Health Melbourne Brain Centre